You can’t get far with $150,000 in drug development, a painful realization that 9 Meters Biopharma knows all too well, as the North Carolina-based biotech filed for bankruptcy. The company disclosed ...
9 Meters Biopharma, Inc., is a clinical-stage company pioneering novel treatments for people with rare digestive diseases, GI conditions with unmet needs, and debilitating disorders in which the ...
Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - Drug developer 9 Meters Biopharma and its units have filed for Chapter 11 bankruptcy protection, it said in a ...
9 Meters Biopharma’s celiac disease drug isn’t measuring up in a phase 3 trial. After an interim analysis found that the study needs an enrollment count that is too large to support continuation, the ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min 9 Meters Biopharma shut down ...
9 Meters Biopharma Inc NMTR shares plummeted after the company filed for Chapter 11 bankruptcy protection, according to a regulatory filing on Tuesday. The company said that after considering all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results